Cancer-specific region of hypermethylation identified within the HIC1 putative tumour suppressor gene in acute myeloid leukaemia

Leukemia

Volumn 13, Issue 6, 1999, Pages 877-883

  Melki, J R ^a   Vincent, P C ^a   Clark, S J ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b CSIRO   (Australia)

Author keywords

Bisulphite genomic sequencing; Cancer; Dna methylation; HIC1; Leukaemia; Tumour suppressor gene

Indexed keywords

DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 17P; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EXON; GENE SEQUENCE; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; INTRON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033046553     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401401     Document Type: Article

References (23)

1. Melki J, Warnecke P, Vincent P, Clark S. Increased DNA methyl-transferase expression in leukemia. Leukemia 1998; 12: 311-316.
2. el-Deiry WS, Nelkin BD, Celano P, Yen RW, Falco JP, Hamilton SR, Baylin SB. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 1991; 88: 3470-3474.
3. Jones PA, Rideout WM, Shen J-C, Spruck CH, Tsai C. Methylation, mutation and cancer. Bioessays 1992; 14: 33-36.
4. Schmutte C, Yang AS, Nguyen TT, Beart RW, Jones PA. Mechanisms for the involvement of DNA methylation in colon carcinogenesis. Cancer Res 1996; 56: 2375-2381.
5. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141-196.
6. Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong AJ, Godwin AK. Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res 1996; 56: 1997-2002.
7. Makos M, Nelkin BD, Lerman MI, Latif F, Zhar B, Baylin SB. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 1992; 89: 1929-1933.
8. Fujii H, Biel MA, Zhou W, Weitzman SA, Baylin SB, Gabrielson E. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogens 1998; 16: 2159-2164.
9. Issa JP, Zehnbauer BA, Kaufmann SH, Biel MA, Baylin SB. HICl hypermethylation is a late event in hematopoietic neoplasms. Cancer Res 1997; 57: 1678-1681.
10. Baylin SB, Fearon ER, Vogelstein B, de Bustros A, Sharkis SJ, Burke PJ, Staal SP, Nelkin BD. Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood 1987; 70: 412-417.
11. Issa JP, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, Davidson NE, Kaufmann SH, Baylin SB. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 1996; 56: 973-977.
12. Herman JG, Jen J, Merlo A, Baylin SB. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 1996; 56: 722-727.
13. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990-2997.
14. Makos-Wales M, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med 1995; 1: 570-577.
15. Warnecke PM, Stirzaker C, Melki JR, Millar DS, Paul CL, Clark SL. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 1997; 25: 4422-4426.
16. Gonzalgo ML, Hayashida T, Bender CM, Pao MM, Tsai YC, Gonzales FA, Nguyen HD, Nguyen TT, Jones PA. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res 1998; 58: 1245-1252.
17. Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ. Detailed methylation analysis of the glurathione S-transferase π (GSTPI) gene in prostate cancer. Oncogene 1999; 18: 1313-1324.
18. Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF, Barlow DP. Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 1997; 389: 745-749.
19. Burke TW, Kadonaga JT. The downstream core promoter element. DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev 1997; 11: 3020-3031.
20. Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, Temper V, Razin A, Cedar H. Sp1 elements protect a CpG island from de novo methylation. Nature 1994; 371: 435-438.
21. Macleod D, Charlton J, Mullins J, Bird AP. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Gene Dev 1994; 8: 2282-2292.
22. Clark SJ, Harrison J, Molloy PL. Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene 1997; 195: 67-71.
23. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196: 261-282.